HealthVerity

🗓️ ISPOR is coming to Philadelphia, and we're ready to roll! Join Alexa Woodward, PhD at Booth 1004 to talk oncology and real-world evidence. ➡️ Schedule time or learn more: https://hubs.ly/Q04f3tTT0 #ISPOR2026 #ISPOR

By year three, only 20% of HIV patients adhere to treatment. A recent RWE study, powered by HealthVerity Marketplace, shows where adherence breaks down and how RWD can guide better interventions. ➡️ https://hubs.ly/Q04dPdX70 Explore what research is possible with HealthVerity Marketplace: https://hubs.ly/Q04dPgqy0

As the Director of RWD Insights, John Cosenza, puts it, most teams assume cost data will be ready when they need it, but inconsistent fields and missing values can make even basic analyses hard to trust. That challenge is exactly what led us to prioritize a new approach to standardizing cost data across sources and filling critical gaps. Watch the webinar to see how it works in practice ➡️ https://hubs.ly/Q04dpqlG0

Yesterday was Bring Your Kid to Work Day and HealthVerity got a colorful makeover to celebrate! Seeing innovation through the eyes of kids was a great reminder that behind every data point is curiosity and imagination. We were thrilled to welcome next generation of thinkers who will shape what’s possible for medical innovation.

In this article, John Cosenza discusses why billed and allowed amounts don’t always tell the full story in closed claims data. ➡️ Read the article: https://hubs.ly/Q04cZVWc0 to see how taXonomy market costs deliver a more consistent, reliable cost signal for RWE and stay tuned for our upcoming cost methodology webinar tomorrow at 11:00am ET.

At HealthVerity, we focus on turning fragmented real-world data into evidence you can trust, even when research questions span safety, effectiveness, utilization and access. ▶️ https://hubs.ly/Q04cKgQW0 Watch the webinar replay above to hear from Ian Livingstone and see how we help teams build credible, defensible evidence in the GLP-1 space.

In this blog, Chris Frederick, lead solutions engineer, shares how clinical data integration and privacy-preserving identity management enable better data linkage and patient journeys ➡️ https://hubs.ly/Q04czNVx0 Read how to turn fragmented data into evidence you can trust and stay tuned for the full whitepaper.

Good enough” data can still carry hidden risk. Read to find out what most teams miss when evaluating real-world data, and why it matters ➡️ https://hubs.ly/Q04bZcvc0 From provenance to patient matching, small gaps can change big decisions.

Rare disease targeting breaks down when audiences rely on assumptions over clinical reality. Our campaign achieved 3x greater qualified patient reach using HealthVerity Audiences. Learn how ➡️ https://hubs.ly/Q04c1rGR0

WEBINAR ALERT: Cost data in real-world evidence: Pitfalls, best practices and new approaches. REGISTER here ➡️ https://hubs.ly/Q04bWTDG0 Cost data shapes decisions that determine which therapies get reimbursed, how treatments are priced and how value is defended in HEOR and market access submissions, yet most teams inherit cost fields from their data and never question where those numbers come from. In this webinar, we break down where cost analyses go wrong and show how to avoid flawed assumptions that can derail your study, invite scrutiny from stakeholders and weaken the case for your therapy. 📅 April 23rd, 2026 ⏰ 11:00 a.m. ET What you’ll learn: ✅ The impact of missing values, payer mix bias and black-box imputation ✅ The difference between payer & market costs, and when each is used ✅ How to evaluate cost variables to strengthen HEOR and RWE studies